Robert Forgey | President & Chief Executive Officer
Iaso Therapeutics, Inc.

Robert W. Forgey is a seasoned life sciences executive and entrepreneur with a proven track record of driving success in both emerging and established companies. As President & CEO of Iaso Therapeutics, he spearheads the company's strategic vision, securing crucial seed funding and guiding successful grant applications. His expertise spans the entire drug development lifecycle, from foundational research to clinical operations. At ONL Therapeutics, he established robust quality management systems, laying the groundwork for sustained growth. Robert's entrepreneurial spirit shines through his founding of ProNAi Therapeutics, where he raised over $20 million in venture capital and led the development of novel cancer therapies. With a strong foundation in research science, honed during his tenure at Searle, Pharmacia, and Pfizer, Robert possesses a deep understanding of drug discovery and development. His experience extends to corporate engagement and technology commercialization, notably at the University of Chicago and Michigan State University Foundation. Robert's ability to build and lead cross-functional teams, manage strategic alliances, and secure financing makes him a valuable speaker on topics ranging from biotech entrepreneurship and drug development to corporate partnerships and innovation.